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Abstract
Background: The metabolic syndrome has been shown to increase the incidence of cardiovascular disease. Little
information exists on the prevalence of the metabolic syndrome for southern Chinese. We therefore investigate the
prevalence of the metabolic syndrome in a southern Chinese population with 85 million residents.
Methods: The Guangdong Nutrition and Health Survey 2002 is a cross-sectional survey designed to assess the
health and nutritional status of 85 million residents in Guangdong province located in southern China. Stratified
multistage random sampling method was applied in this survey and a provincial representative sample of 6,468
residents aged 20 years or above was obtained in the present study. The participants received a full medical check-
up including measurement of blood pressure, obesity indices, fasting lipids and glucose levels. Data describing
socioeconomic and lifestyle factors was also collected through interview. Metabolic syndrome was defined in
accordance with the International Diabetes Federation criteria.
Results: The prevalence of metabolic syndrome was 7.30%, translating into a total of 4.0 million residents aged 20
years or above having the condition in this southern Chinese population. The urban population had higher
prevalence of the syndrome than the rural population (10.57% vs 4.30%). Females had a higher prevalence of
metabolic syndrome than males (8.99% vs 5.27%). More than 60% of the adults had at least one component of the
metabolic syndrome.
Conclusions: Our results indicate that a large proportion of southern Chinese adults have the metabolic syndrome
and associated risk factors. The metabolic syndrome has become an important public health problem in China.
These findings emphasize the urgent need to develop population level strategies for the prevention, detection,
and treatment of cardiovascular risk in China.
Background
Cardiovascular disease is the leading cause of mortality
in China as well as worldwide [1,2]. The constellation of
cardiovascular risk factors including abdominal obesity,
raised fasting glucose level and dislipidemia is termed
the metabolic syndrome (MetSyn). The MetSyn has
been associated with increased risk of diabetes, cardio-
vascular disease and subsequent mortality. In recent
decades with its rapid economic growth and aging
population China has experienced a cardiovascular dis-
ease epidemic.
As China is a country with a population of 1.3 billion
living in a large geographical area, the variations in
demographic characteristics, cultural behaviors and life-
style habits vary substantially in different regions. This
may result in differing disease prevalences in different
populations. A nationwide survey by Gu et al has shown
that the prevalence of MetSyn varied geographically in
China [3]. The prevalence of obesity component in
northern China was shown to be two-fold higher than
that in southern China [3]. Data on the MetSyn preva-
lence for different populations with relatively
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homogeneous characteristics are necessary for develop-
ing prevention strategies at population level. There were
quite a number of studies concerning the prevalence of
the MetSyn among Chinese in the last decade [3-7].
However, most of these studies are small-scale, investi-
gations. They either focused on special groups, such as
professionals or elderly, or were restricted in one or sev-
eral small communities. Large scale, representative,
population-based survey in China is rare, especially for
southern Chinese.
Guangdong is the province located in southern China
with a population of 85 million permanent residents. Its
capital is Canton, which is about 180 kilometers north
of Hong Kong. Cantonese people have relatively unique
culture and lifestyle as compared to northern Chinese.
In addition, Guangdong is the first province where the
Chinese leader Deng Xiao Ping started the economic
reform and open policy in 1979. When compared with
other inland provinces, Guangdong is more economic-
ally developed and urbanized. In order to elucidate the
present situation of the MetSyn in this Cantonese popu-
lation, we report its prevalence based on the data from
the Guangdong Nutrition and Health Survey 2002
(GNHS 2002) [8].
Methods
The Guangdong Nutrition and Health Survey (GNHS)
2002 was conducted by the Guangdong Province Center
for Disease Control and Prevention (CDC) and the
Health Bureau of Guangdong Province in 2002. The
GNHS 2002 corresponded with the China National
Nutrition and Health Survey (CNNHS) 2002 [9-11],
which covered 31 provinces, autonomous regions, and
municipalities nationwide. Based on the CNNHS 2002
sampling protocols, eight urban areas or rural villages in
Guangdong province were required to be sampled as a
part of the CNNHS 2002. In order to have sufficient sta-
tistical power to analyze the provincial data indepen-
dently and to obtain more reliable health information
for the provincial population as a whole, five additional
urban areas or rural villages were sampled in the GNHS
2002. Therefore, the GNHS 2002 has a representative
provincial population sample from a total of 13 urban
areas or rural villages (six urban city districts and seven
rural villages) [8]. Ethics approval was obtained from the
Ethics Committee of China Centre for Disease Control.
All participants gave informed consent prior to the
survey.
The sampling methods and survey protocols as well as
the quality control for the GNHS 2002 were similar to
those for the CNNHS 2002 [9-11]. The stratified multi-
stage cluster sampling with probability proportional to
size method was used. Briefly, the cities and counties of
the province were classified into four strata (large cities;
small to medium cities; class 1 and class 2 rural areas)
based on their economic development levels identified
by the central government of China. The first stage
systemic sampling was conducted in each stratum:
three districts from the large cities, three districts from
the small to medium cities, four counties from the
class 1 rural areas and three counties from the class 2
rural counties were randomly selected based on the
population size. The second stage sampling was subse-
quently conducted in each selected districts or coun-
ties: three neighborhoods (urban) or townships (rural)
were sampled from each selected districts or counties
using the same systematic random sampling methods
as that in the first stage. In the third stage, two resi-
dential committees (urban) or villages (rural) were
sampled from each selected neighborhood or town-
ships using the same systematic random sampling
methods as those in the first and second stages. In the
fourth stage, around 90 households with a record in
the household registration system from each residential
committees or villages were randomly sampled (the
households in the registration system generally do not
include migrant workers). All members of the selected
household were invited to participate in the health sur-
vey, including a questionnaire interview and a general
health examination. The overall response rate for the
health survey was 89.45%. A total of 78 residential
committees or villages and 7,180 households were
finally included in the GNHS 2002 with 25,459 partici-
pants, representing the Guangdong provincial perma-
nent residential population of 85,221,747 in 2000 [12].
In addition to the general questionnaire interview and
health examination, a third of the sampled households
(2,424 households with 9,509 all age residents) were
randomly selected for dietary intake examination, as
well as blood sample laboratory test including fasting
glucose and lipids profiles. Therefore, a total of 6,468
participants aged 20 years or above were included in
the present analysis.
A central survey site was set up in each residential
committee or village and the participants were required
to be interviewed and receive the health examination
on-site. All interviews and examinations following stan-
dardized protocols were conducted by physicians who
received training specifically for the GNHS 2002. The
questionnaire interview collected a wide range of infor-
mation including demographic characteristics, life style
and family and personal disease histories. Weight and
height were measured with light indoor clothing and
without shoes. Waist circumference measurement was
made at minimal inspiration to the nearest 0.1 cm, mid-
way between the lowest rib and the superior border of
the iliac crest. Both weight and waist were measured in
the morning before breakfast.
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The blood pressure measurement was based on the
1999 World Health Organization/International Society
of Hypertension guidelines on hypertension [13]. Two
consecutive readings of the blood pressure on right
arms were taken after the participant in a seated posi-
tion for 5 minutes rest. The average of the two readings
was used for analysis.
Blood samples were drawn in the morning after an
overnight fast using vacutainer tubes. Plasma glucose
was measured within three hours after obtaining the
blood sample using a spectrophotometer 721/722. For
those participants with a plasma glucose level of 5.50
mmol/l or above, an Oral Glucose Tolerance Test
(OGTT) was performed on the subsequent sixth day.
Additional plasma samples were stored in airtight tubes
at -80°C prior to shipment on dry ice to the CDC for
the measurement of the lipids. Total cholesterol, trigly-
ceride and HDL-cholesterol were determined using a
Hitachi 7060 Automatic Chemical Analyzer in the CDC
laboratory.
The International Diabetes Federation criteria (IDF)
were used to define MetSyn in the present study
because this definition considers the ethnic difference
for central obesity. According to the IDF criteria, parti-
cipants are classified as having MetSyn if they have cen-
tral obesity (waist circumference > 90 cm for men and >
80 cm for women) plus any other two abnormalities of
those shown below:
1. Hypertension: systolic blood pressure ≧ 130 mmHg,
Or diastolic blood pressure ≧ 85 mmHg, or treatment of
previously diagnosed hypertension;
2. Hypertriglyceridemia: ≧ 1.7 mmol/l or specific med-
ical treatment for this lipid abnormality;
3. Hypo-HDL-cholesterol: < 1.03 mmol/l for males or
< 1.29 mmol/l for females;
4. Raised fasting glucose: overnight ≧5.6 mmol/l.
The present study included all men and women aged
20 years or older. All data analyses were performed
using SAS software, version 9.2 (SAS Institute, Cary,
NC, USA). In a manner, similar to our previous survey
analysis for the U.S. National Health and Nutrition
Examination Survey (NHANES) [14], the GNHS 2002
adopted a stratified multistage cluster sampling design.
As such, the survey design parameters including weight,
stratum and cluster were incorporated into all analyses.
The weight was derived based on the provincial 2000
census data and associated administrative data. These
weights account for the stratified multistage and the
unequal selection probability survey design. The non-
response information was also incorporated into the
weight. PROC SURVEYMEANS and PROC SURVEY-
FREQ were used for the calculation of means and preva-
lence. All means and prevalence calculated in this study
represented the overall estimates for the corresponding
population aged 20 years or above in Guangdong pro-
vince. PROC SURVEYREG and PROC SURVEYLOGIS-
TIC were used to assess the differences between
categories. Two sided p values of less than 0.05 were
considered statistically significant. 95% confidence inter-
vals were calculated and presented in the present study.
Domain statement was used for the subpopulation
analyses.
Results
The GNHS 2002 included a representative sample of
6,468 residents aged 20 years or above with biochemical
test results. The mean age of the population was 44.91
(43.63, 46.19). Table 1 presents the risk factors for Met-
Syn among the population stratified by sex and region.
Compared to rural population, participants in the urban
population were older and had higher BMI, waist cir-
cumference, total cholesterol, triglyceride and fasting
glucose levels. The female population in the urban set-
tings was more educated than those in the rural settings,
while male participants in rural regions consumed more
tobacco than in urban areas. There were no significant
differences between urban and rural populations for
blood pressure and HDL-cholesterol, or for alcohol con-
sumption. Compared to females, male participants gen-
erally had a higher waist circumference, diastolic blood
pressure, triglycerides, as well as a lower HDL-choles-
terol level. Male participants were more educated and
consumed much more tobacco and alcohol than the
females.
The prevalence of the MetSyn in this population was
7.30%. Table 2 presents the prevalence of the MetSyn as
well as the individual components among the population
stratified by regions and sex. Compared to the rural
population, the urban population had higher prevalence
of the MetSyn. The urban population generally had
higher prevalence of most individual components,
except for low HDL-cholesterol levels. Compared to
females, male residents had lower prevalence of central
obesity and low HDL-cholesterol, but a higher preva-
lence of hypertension and high triglycerides. There was
no significant sex difference in the prevalence of raised
fasting glucose.
Table 3 presents the prevalence of the MetSyn in the
population stratified by age, sex and region. The preva-
lence of MetSyn generally increased significantly with
increasing age. Figure 1 shows the sex and region-speci-
fic prevalence of population with one or more compo-
nents of the MetSyn. A total of 60.16% of the
population aged 20 years or above had at least one com-
ponent of MetSyn. The proportions of having at least
one component of MetSyn among urban male, urban
female, rural male and rural female populations were
77.00%, 77.54%, 46.86% and 59.38%, respectively.
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Discussion
The results of the representative, population-based GHNS
2002 show that the prevalence of the MetSyn based on the
IDF criteria was common in this southern Chinese popu-
lation at 7.30%. This translates into a total of 4.0 million
adults having MetSyn in Guangdong province which has a
population of 85 millions (around 55 million residents 20
years of age or above), with more than 60% having at least
one individual component of MetSyn. The urban popula-
tion had higher prevalence of MetSyn than the rural popu-
lation (10.57% vs 4.30%). Female had higher prevalence of
MetSyn than male (8.99% vs 5.27%).
Comparisons of the prevalence rates of MetSyn with
other populations are generally difficult due to its
Table 1 Anthropometric, blood pressure and plasma biochemical characteristics in the population aged 20 years or
above by sex and region
Male (3,148) Female (3,320) P
Age (years) Urban 47.70 (45.24, 50.16) 46.35 (44.14, 48.56) < 0.001
Rural 43.47 (41.83, 45.11) 43.18 (41.64, 45.11) 0.68
p 0.010 0.026
Body Mass Index (kg/m2) Urban 23.29 (22.83, 23.75) 23.03 (22.83, 23.23) 0.28
Rural 21.05 (20.29, 21.82) 21.02 (20.63, 21.41) 0.89
p < 0.001 < 0.001
Waist circumference (cm) Urban 80.61 (79.80, 81.45) 74.52 (72.19, 76.86) < 0.001
Rural 74.95 (73.62, 76.27) 71.71 (71.03, 72.40) < 0.001
p < 0.001 0.028
Systolic blood pressure (mmHg) Urban 123.48 (120.79, 126.16) 119.93 (116.65, 123.20) 0.002
Rural 119.52 (115.57, 123.47) 117.57 (111.52, 123.62) 0.25
p 0.094 0.46
Diastolic blood pressure (mmHg) Urban 78.43 (77.04, 79.81) 74.34 (72.83, 75.85) < 0.001
Rural 76.76 (75.77, 77.74) 74.52 (73.39, 75.65) 0.002
p 0.053 0.84
Total cholesterol (mmol/L) Urban 4.52 (4.41, 4.64) 4.55 (4.41, 4.70) 0.43
Rural 4.19 (4.01, 4.37) 4.14 (4.03, 4.25) 0.32
p 0.007 < 0.001
HDL-cholesterol (mmol/L) Urban 1.27 (1.15, 1.34) 1.38 (1.31, 1.44) < 0.001
Rural 1.32 (1.26, 1.38) 1.40 (1.32, 1.48) 0.028
p 0.20 0.63
Triglyceride (mmol/L) Urban 1.37 (1.25, 1.49) 1.17 (1.02, 1.32) 0.001
Rural 1.05 (0.95, 1.15) 0.96 (0.93, 1.00) 0.034
p 0.001 0.015
Fasting glucose (mmol/L) Urban 5.08 (4.95, 5.21) 5.10 (4.97, 5.23) 0.25
Rural 4.90 (4.75, 5.06) 4.81 (4.67, 4.94) 0.019
p 0.078 0.006
Education (no formal school education) Urban 97.90 (96.34, 99.46) 90.21 (85.47, 94.94) < .0001
Rural 97.48 (96.42, 98.53) 83.49 (78.41, 88.57) < .0001
p 0.63 0.037
Tobacco consumptions (ever) Urban 45.53 (39.34, 51.72) 2.33 (1.08, 3.58) < 0.001
Rural 57.49 (50.00, 64.98) 0.86 (0.00, 2.11) < 0.001
p 0.006 0.14
Alcohol consumptions (ever) Urban 33.84(31.15, 36.53) 4.40 (2.28, 6.53) < 0.001
Rural 30.56 (25.38, 35.75) 4.45 (3.04, 5.86) < 0.001
p 0.21 0.97
Values were presented in mean (95% CI) for continuous variables and prevalence (95% CI) for categorical variables
Smoking in the present study was defined as currently smoking or having at least one cigarette daily for six months or above.
Alcohol consumption was defined as currently or once having one drink at least once per week over the last 12 months.
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varying definitions specified by different international
authorities. The National Cholesterol Education Pro-
gramme Adult Treatment Panel (NCEP ATP) III is the
most widely utilized to date, especially for those studies
conducted in western populations. However, it is not
appropriate to use NCEP ATP III for defining central
obesity for Chinese owing to the disproportionate con-
tribution of obesity to the development of cardiovascular
diseases in Asians [15-18], and thus lower thresholds of
≧ 80 or ≧ 90 cm in females and males, respectively for
defining central obesity have been recommended by the
WHO [19,20]. In addition to central obesity, the NCEP
ATP III criterion (2001) for Hyperglycaemia is ≧ 6.1
mmol/L, while the IDF criterion is 5.6 mmol/L. Other-
wise the definitions for the other three components,
namely hypertriglyceridemia, hypo-HDL-cholesterol and
hypertension, are the same. Nonetheless, the prevalence
of MetSyn using the IDF criteria in our population
(7.30%) is much lower than those of MetSyn among the
American adults aged 20 years or above in NHANES III
Table 2 Prevalence of individual components of the metabolic syndrome based on International Diabetes Federation
guidelines in southern Chinese aged 20 years or above
Male Female p
Central obesity Urban 16.58 (13.51, 19.65) 25.50 (15.94, 35.07) 0.003
Rural 6.56 (3.90, 9.22) 15.35 (12.66, 18.05) < 0.001
p < 0.001 0.008
Hypertension Urban 40.45 (32.81, 48.09) 31.52 (25.20, 37.83) < 0.001
Rural 27.26 (19.82, 34.70) 24.62 (15.19, 34.05) 0.16
p 0.006 0.19
hypertriglyceridaemia Urban 24.52 (18.16, 30.88) 17.37 (9.46, 25.29) 0.006
Rural 8.92 (7.06, 10.77) 5.61 (4.90, 6.33) < 0.001
p < 0.001 < 0.001
Low HDL-cholesterol Urban 25.22 (12.88, 37.57) 40.89 (35.27, 46.51) 0.002
Rural 16.04 (11.03, 21.05) 40.40 (28.96, 51.85) < 0.001
p 0.088 0.93
Hyperglycaemia: Urban 14.36 (10.95, 17.78) 13.55 (10.75, 16.35) 0.56
Rural 9.52 (2.37, 16.65) 7.26 (2.93, 11.59) 0.053
p 0.2273 0.0222
MetSyn Urban 8.56 (7.82, 9.30) 12.18 (9.25, 15.11) < 0.001
Rural 2.45 (1.12, 3.79) 5.94 (2.95, 8.92) 0.005
p < 0.001 0.003
Total MetSyn in the whole population 5.27 (4.19, 6.39) 8.99 (6.84, 11.14) 0.036
Table 3 Prevalence of the Metabolic syndrome in the population by age, sex and region
Total (n = 6468) Age group (years) P for trend
20-39 (n = 2942) 40-59 (n = 2277) 60-(n = 1249)
All regions
Men 5.27 (4.19, 6.39) 2.70 (1.53, 3.87) 6.14 (3.80, 8.47) 7.83 (5.60, 10.05) 0.001
Women 8.99 (6.84, 11.14) 2.18 (1.07, 3.29) 9.88 (7.38, 12.38) 21.85 (14.72, 28.99) < 0.001
Total 7.30 (5.78, 8.82) 2.40 (1.58, 3.22) 8.16 (6.41, 9.90) 14.69 (10.87, 18.51) < 0.001
Urban
Men 8.56 (7.82, 9.30) 4.11 (2.29, 5.93) 10.39 (7.82, 12.96) 11.87 (9.33, 14.42) < 0.001
Women 12.18 (9.25, 15.11) 2.85 (0.99, 4.71) 12.68 (8.29, 17.07) 27.58 (20.87, 34.29) < 0.001
Sub total 10.57 (9.02, 12.13) 3.39 (2.03, 4.75) 11.72 (9.01,14.44) 19.60 (15.55, 23.65) < 0.001
Rural
Men 2.45 (1.12, 3.79) 1.52 (0.059, 2.99) 3.09 (0.20, 5.97) 2.82 (0.01, 6.67) 0.65
Women 5.94 (2.95, 8.92) 1.62 (0.30, 2.94) 7.15 (4.10, 10.20) 14.59 (1.01, 28.17) < 0.001
Sub total 4.30 (2.11, 6.49) 1.58 (0.57, 2.59) 5.14 (2.85, 7.44) 8.54 (1.53, 15.55) 0.011
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Figure 1 Gender and region-specific prevalence of the International Diabetes Federation (IDF)-based metabolic syndrome components
in southern China.
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(27.9%) and NHANES 1999-2006 (34.1%) using the defi-
nition by NCEP ATP III [21]. In a study by Ford et al.,
they analyzed the NHANES 1999-2002 data using the
IDF definition, and found the prevalence of the MetSyn
among American adults was 34.5% [22].
Previous studies showed that MetSyn was prevalent in
China. In the InterASIA study [3], Gu et al reported the
age-standardized prevalence of MetSyn as 9·8% for men
and 17·8% for women using the modified NCEP ATP III
definition (the waist circumference criterion for central
obesity was modified as ≧80 for female and ≧90 cm for
males) in a nationwide, representative sample. They also
found that the prevalence was higher in urban area than
in rural area, and in female than in male, which is com-
patible with our findings. Yang et al compared the pre-
valence using the NCEP ATP III and IDF definitions in
the InterASIA study, and they found that the prevalence
by IDF was higher than that by NCEP ATP III (23.3% vs
16.5%) [23]. Reports on Cantonese population are rela-
tively limited. Guangdong province was not included in
the InterASIA study [3]. A study by Li et al reported the
prevalence was 26.7% using the modified NCEP ATP III
definition among the 1,206 participants with a mean age
of 59.10 years who attended a medical examination cen-
tre [4]. The advantage of our study is that we included a
representative sample targeting to the whole population
with 85 million residents in Guangdong province. How-
ever, large scale survey has limitations (e.g., nonsample
errors including nonresponse, coverage errors and mea-
surement errors), which may influence the accuracy of
estimation.
We previously conducted a study on MetSyn in Can-
ton city using the IDF definition [16,24]. The preva-
lence of the MetSyn in that study was 25.81% in the
urban participants aged 50 years above, which was
higher than the prevalence of the present study (the
prevalence of the MetSyn were 11.71% and 19.60%
among the age group 40- and age group 60- urban
populations, respectively). However, the participants of
the previous study were members of a community
social and welfare association, who generally have a
higher social status than participants from the general
population. In addition, there were more women than
men in our previous study [16]. The incidence of the
MetSyn increases substantially during perimenopause
and early menopause [25]. Our present study showed
that the prevalence of the MetSyn in women jumped
from 9.88% in 40- age group to 21.85% in the 60- age
group (Table 3).
The MetSyn is a constellation of cardiovascular risk
factors. As the prevalence of cardiovascular risk factors
continues to increase, in particular obesity, MetSyn is
becoming increasingly recognized as an important pub-
lic health concern worldwide [26]. In the United States,
one-third of adults have MetSyn. The goal of developing
the MetSyn concept is to identify individuals at high
risk of cardiovascular disease or type 2 diabetes to
enable targeted interventions to be introduced to pre-
vent the development of the conditions.
Conclusions
Our results showed that the prevalence of the MetSyn
was high in this southern Chinese population. We esti-
mate a total of 4.0 million southern Chinese adult resi-
dents have the MetSyn. However, more surveys are
needed to assess the changes in trends of the prevalence
of MetSyn in this population. Mozumdar et al have
reported that the prevalence of the MetSyn increased
from 27.9% to 34.1% during a period of around a decade
in the United States [21]. China has the fastest eco-
nomic development in the world. As China increases its
rate of modernization and becomes more urbanized,
more people are likely to have increasingly sedentary
lifestyles and consumption of energy-dense diets. The
prevalence of MetSyn and related cardiovascular disease
is therefore expected to increase enormously. Clearly,
without prevention and aggressive treatment of these
conditions, the potential socioeconomic, medical and
societal ramifications in China could be overwhelming.
Urgent public health actions are needed to control this
observed worsening situation in China.
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